Drug Approval | October 27, 2022
Zydus gets USFDA’s approval for Ketorolac Tromethamine Tablets
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
The CRL did not identify any outstanding scientific issues with the product.
Approval based on HIMALAYA Phase III trial results which showed single priming dose of Imjudo added to Imfinzi reduced risk of death by 22% vs. sorafenib
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
The girl child anthem will portray a celebration of a girl child.
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism resulting in toxic sulfite levels causing neurologic sequelae
Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data
The symposium was organized to provide an opportunity to highlight the advances of aortic surgery and to discuss the future of aortic aneurysm management.
Subscribe To Our Newsletter & Stay Updated
